160 related articles for article (PubMed ID: 32889249)
1. Metachronous hepatic resection for liver only pancreatic metastases.
Schwarz C; Fitschek F; Primavesi F; Stättner S; Margonis GA; Weiss MA; Stavrou GA; Oldhafer KJ; Kornprat P; Wundsam H; Fischer I; Längle F; Függer R; Hauer A; Klug R; Kieler M; Prager G; Schindl M; Stremitzer S; Bodingbauer M; Sahora K; Kaczirek K
Surg Oncol; 2020 Dec; 35():169-173. PubMed ID: 32889249
[TBL] [Abstract][Full Text] [Related]
2. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
3. Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis.
Tachezy M; Gebauer F; Janot M; Uhl W; Zerbi A; Montorsi M; Perinel J; Adham M; Dervenis C; Agalianos C; Malleo G; Maggino L; Stein A; Izbicki JR; Bockhorn M
Surgery; 2016 Jul; 160(1):136-144. PubMed ID: 27048934
[TBL] [Abstract][Full Text] [Related]
4. Patients with hepatic oligometastatic pancreatic body/tail ductal adenocarcinoma may benefit from synchronous resection.
Yang J; Zhang J; Lui W; Huo Y; Fu X; Yang M; Hua R; Wang L; Sun Y
HPB (Oxford); 2020 Jan; 22(1):91-101. PubMed ID: 31262486
[TBL] [Abstract][Full Text] [Related]
5. Dose surgical resection of hepatic metastases bring benefits to pancreatic ductal adenocarcinoma? A systematic review and meta-analysis.
Yu X; Gu J; Fu D; Jin C
Int J Surg; 2017 Dec; 48():149-154. PubMed ID: 29081375
[TBL] [Abstract][Full Text] [Related]
6. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
[TBL] [Abstract][Full Text] [Related]
7. Surgery for isolated liver metastases from pancreatic cancer.
Zanini N; Lombardi R; Masetti M; Giordano M; Landolfo G; Jovine E
Updates Surg; 2015 Mar; 67(1):19-25. PubMed ID: 25702263
[TBL] [Abstract][Full Text] [Related]
8. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
9. A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy.
Crippa S; Cirocchi R; Weiss MJ; Partelli S; Reni M; Wolfgang CL; Hackert T; Falconi M
Updates Surg; 2020 Mar; 72(1):39-45. PubMed ID: 31997233
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection of synchronous and metachronous metastases from pancreatic adenocarcinoma. Two case reports in the light of recent evidences.
Cannistra' M; Ruggiero M; Zullo A; Grande R; Nardo B
Ann Ital Chir; 2015 Dec; 86(ePub):S2239253X15024160. PubMed ID: 26754676
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
[TBL] [Abstract][Full Text] [Related]
12. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
14. [Is liver resection in metastases of exocrine pancreatic carcinoma justified?].
Klempnauer J; Ridder GJ; Piso P; Pichlmayr R
Chirurg; 1996 Apr; 67(4):366-70. PubMed ID: 8646923
[TBL] [Abstract][Full Text] [Related]
15. Benefits of Laparoscopic Approach for Resection of Liver Tumors in Cirrhotic Patients.
Le Roux F; Rebibo L; Cosse C; Chatelain D; Nguyen-Khac E; Badaoui R; Regimbeau JM
J Laparoendosc Adv Surg Tech A; 2018 May; 28(5):553-561. PubMed ID: 29350570
[TBL] [Abstract][Full Text] [Related]
16. The role of hepatectomy for synchronous liver metastases from pancreatic adenocarcinoma.
Andreou A; Knitter S; Klein F; Malinka T; Schmelzle M; Struecker B; Schmuck RB; Noltsch AR; Lee D; Pelzer U; Denecke T; Pratschke J; Bahra M
Surg Oncol; 2018 Dec; 27(4):688-694. PubMed ID: 30449494
[TBL] [Abstract][Full Text] [Related]
17. Time interval-based indication for liver resection of metastasis from pancreatic cancer.
Mitsuka Y; Yamazaki S; Yoshida N; Yan M; Higaki T; Takayama T
World J Surg Oncol; 2020 Nov; 18(1):294. PubMed ID: 33172482
[TBL] [Abstract][Full Text] [Related]
18. Radical surgery of oligometastatic pancreatic cancer.
Hackert T; Niesen W; Hinz U; Tjaden C; Strobel O; Ulrich A; Michalski CW; Büchler MW
Eur J Surg Oncol; 2017 Feb; 43(2):358-363. PubMed ID: 27856064
[TBL] [Abstract][Full Text] [Related]
19. Vascular resection for locally advanced pancreatic ductal adenocarcinoma: analysis of long-term outcomes from a single-centre series.
Feo CF; Deiana G; Ninniri C; Cherchi G; Crivelli P; Fancellu A; Ginesu GC; Porcu A
World J Surg Oncol; 2021 Apr; 19(1):126. PubMed ID: 33866970
[TBL] [Abstract][Full Text] [Related]
20. A case of metachronous oligo-hepatic and peritoneal metastases of pancreatic cancer with a favorable outcome after conversion surgery combined with perioperative sequential chemotherapy.
Tohyama T; Tanno Y; Murakami T; Hayashi T; Fujimoto Y; Takehara K; Seshimo K; Fukuhara R; Omori M; Matsumoto T
Clin J Gastroenterol; 2024 Apr; 17(2):371-381. PubMed ID: 38291249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
